Hot Pursuit     14-Feb-24
Zydus Lifesciences Ltd soars 0.37%, rises for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 860.95, up 0.37% on the day as on 12:44 IST on the NSE. The stock is up 83.45% in last one year as compared to a 20.24% spurt in NIFTY and a 50.77% spurt in the Nifty Pharma.

Zydus Lifesciences Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 860.95, up 0.37% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 21661.9. The Sensex is at 71253.61, down 0.42%. Zydus Lifesciences Ltd has risen around 20.1% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has risen around 5.3% in last one month and is currently quoting at 18753.95, down 1.62% on the day. The volume in the stock stood at 5.22 lakh shares today, compared to the daily average of 15.54 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 862.7, up 0.2% on the day. Zydus Lifesciences Ltd is up 83.45% in last one year as compared to a 20.24% spurt in NIFTY and a 50.77% spurt in the Nifty Pharma index.

The PE of the stock is 32.32 based on TTM earnings ending December 23.

Previous News
  Zydus Lifesciences Ltd soars 1.52%, rises for fifth straight session
 ( Hot Pursuit - 11-Mar-24   13:00 )
  Zydus receives USFDA approval for Zinc Sulfate Injection
 ( Corporate News - 24-Aug-23   11:36 )
  Zydus Life Ahmedabad facility clears USFDA inspection
 ( Hot Pursuit - 08-Jul-23   11:47 )
  Zydus Lifesciences acquires 6.5% stake in Mylab Discovery Solutions
 ( Corporate News - 18-Sep-23   17:15 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
 ( Hot Pursuit - 12-Feb-24   13:05 )
  Zydus Life gets USFDA nod for Erythromycin tablets
 ( Hot Pursuit - 10-Mar-23   09:18 )
  Zydus Life gets final USFDA approval for two drugs
 ( Hot Pursuit - 28-Mar-23   10:35 )
  Zydus receives USFDA approval for Levothyroxine Sodium for Injection
 ( Corporate News - 28-Mar-23   10:23 )
  Zydus receives USFDA approval for Loperamide Hydrochloride Capsules
 ( Corporate News - 28-Mar-23   16:12 )
  Zydus Life receives USFDA approval for Zinc Sulfate Injection
 ( Hot Pursuit - 24-Aug-23   11:50 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top